Hydroxyapatite compound

Concise Prescribing Info
Prevention of postmenopausal osteoporosis.
Dosage/Direction for Use
Adult: PO As ossein-hydroxyapatite compd: 1,660 mg twice daily.
Hypersensitivity. Children <6 yr. Prolonged immobilization accompanied by hypercalciuria.
Special Precautions
Monitor serum calcium level during treatment. To be taken with vitamin D for maximal benefit. Caution when used in renally impaired patients.
Adverse Reactions
Risk of hypercalciuria.
Drug Interactions
Biphosphonates may increase the osteoconductive and regenerative properties of hydroxyapatite when used together.
Disclaimer: This information is independently developed by CIMS based on hydroxyapatite compound from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in